Paramount Cosmetics (India) Board of Directors

Get the latest insights into the leadership at Paramount Cosmetics (India). Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Hiitesh Topiiwaalla Managing Director
Ms. Aartii Topiwaala Director
Mr. Mukesh Kumar Tyagi Independent Director
Mr. Vishwaskumar Ashokkumar Sharma Independent Director

Paramount Cosmetics (India) Share price

PARMCOS-B

37.77

1.62 (-4.11%)
Last updated on 4 Sep, 2025 | 15:25 IST
BUYSELL
Today's High

40.00

Today's Low

37.77

52 Week Low

34.00

52 Week High

66.00

The current prices are delayed, login to your account for live prices

Paramount Cosmetics (India) FAQs

The board at Paramount Cosmetics (India) consists of experienced professionals, including Mr. Hiitesh Topiiwaalla , Ms. Aartii Topiwaala , and others, overseeing the company’s strategic and corporate governance.

Directors at Paramount Cosmetics (India) are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Hiitesh Topiiwaalla is the current chairman at Paramount Cosmetics (India).

Executive directors at Paramount Cosmetics (India) are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Paramount Cosmetics (India) adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Paramount Cosmetics (India), board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.